+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Dermal Fillers Market, 2023-2035 - Distribution by Gender, Material, End User, Distribution Channel and Key Geographical Regions: Industry Trends and Forecasts

  • PDF Icon

    Report

  • 34 Pages
  • January 2024
  • Region: Global
  • Roots Analysis
  • ID: 5925450

Next-Gen Fillers and Cannula Technique Propel Dermal Fillers Market Growth

The global dermal filler market size is estimated to be $3 billion in 2023 and is anticipated to grow at a compounded annual growth rate (CAGR) of around 9% over the forecast period 2023-2035. In the continuously evolving field of medical aesthetics, keeping up with the trend has become very important for the developers as well as the consumers. Dermal fillers are a type of injectable treatment which consists of hyaluronic acid in the form of a gel-like substance, also known as facial fillers. Dermal fillers emerged as one of the popular choices among consumers for facial rejuvenation, immediate face lift, scar treatment and lip enhancement. It is interesting to note that, according to the International Society of Aesthetic Plastic Surgery, over 4.3 million hyaluronic acid dermal filler procedures were performed, globally in the year 2022. This can be primarily attributed to minimally invasive nature of the procedure making it suitable for large patient population seeking cosmetic procedures. These procedures can even be non invasive at times, involving minimal or no pain.

Dermal fillers often comprise hyaluronic acid, lactic acid, calcium hydroxyapatite, polymethyl methacrylates and polyacrylamide gels. They are normally injected underneath the skin in the nasolabial folds, marionette lines, cheeks, and oral commissures to create a smoother and fuller appearance in the face. The treatment does not require patients to undergo anesthesia. The effects of the treatment can last from 5 months to 5 years, depending on the type of material used. It is interesting to note that scientists are transforming the field of dermal fillers market by utilizing cannula technique. This approach involves using a blunt-tipped cannula despite a needle to inject fillers, to make the procedure less invasive, minimize bruising, and to permit precise placement. In addition, technological advancements have led to the development of next-generation fillers, such as hyaluronic acid fillers with improved cross-linking properties, offering longer-lasting results. Given the need and rising number for dermal filler treatments with each passing year, dermal filler injection manufacturers are also emerging. All these factors will drive the growth of the dermal fillers market, an important segment of the medical aesthetics market, over the forecast period.

Market Share Insights

The dermal fillers market report presents an in-depth analysis of the various companies that are engaged in the global dermal fillers industry, across different segments, as defined below:

  • Historical Trend: 2018-2022
  • Base Year: 2022
  • Forecast Period: 2023-2035
  • Market Size 2023: $3 Billion
  • CAGR 2023-2035: ~9%
  • Gender
    • Females
    • Males
  • Material
    • Hyaluronic Fillers
    • Non Hyaluronic Acid Fillers
  • End User
    • Hospitals
    • Clinics / Med Spas and Dermatology / Cosmetology Centers
    • Other End Users
  • Distribution Channel
    • Direct Distribution
    • Indirect Distribution
  • Key Geographical Regions
    • North America (U.S., Canada, Mexico)
    • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
    • Asia-Pacific (China, South Korea, Japan, India)
    • MENA (Turkey, Iran, Rest of the Middle East and North Africa)
    • Latin America (Brazil, Argentina, Rest of the Latin America)
  • Key Companies Profiled
    • Allergan Aesthetics
    • Alma Lasers
    • Biotechitalia
    • Bison Medical
    • Koru Pharma
    • MedicalZone
    • Merz Pharma
    • Mesoestetic
    • MesoTech
    • NeoGenesis
    • Sinclair Pharma
    • Xcelene
  • Customization Scope: 15% Free Customization
  • Excel Data Packs (Complimentary)
    • Market Landscape Analysis
    • Clinical Trial Analysis
    • Partnership and Collaboration Analysis
    • Funding and Investment Analysis
    • Patent Analysis
    • Market Forecast an Opportunity Analysis

One of the key objectives of this market report was to estimate the current market size, opportunity and the future growth potential of the dermal fillers market, over the forecast period. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period 2023-2035. The market report also features the likely distribution of the current and forecasted opportunity within the dermal fillers market across various segments, such as gender (females and males), by material (hyaluronic fillers and non-hyaluronic acid fillers), end user (hospitals, clinics / med spas and dermatology / cosmetology centers, and other end users), by distribution channel (indirect distribution and direct distribution) and key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties and to add robustness to the model, the analyst has provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Market Segmentation Overview

Market Share by Gender

Based on gender, the dermal fillers market is analyzed across females and males. Currently, around 87% of the dermal fillers market is dominated by the presence of female clientele.

Market Share by Material

Based on material, the dermal fillers market is analyzed across hyaluronic fillers and non-hyaluronic acid fillers. Currently, hyaluronic acid fillers dominate the dermal fillers market, holding ~90% of the market share.

Market Share by End User

The global dermal fillers market is categorized into hospitals, clinics / med spas and dermatology / cosmetology centers, and other end users. Dermatology clinics and cosmetology centres segment occupy the highest share in 2023 and is expected to stay dominant during the forecast period. Minimally invasive procedures, such as dermal fillers, are relatively simpler and are usually performed at medical spas and dermatology clinics. Further, the hospitals segment, mainly consisting of plastic surgeons, is anticipated to grow at a stable pace in the foreseeable future.

Market Share by Distribution Channel

The dermal fillers market is segmented into direct distribution and indirect distribution. Indirect distribution channels are likely to grow at a higher CAGR as compared to direct distribution channels due to dermal filler companies working more collaboratively with distributors and other e-commerce portals.

Market Share by Key Geographical Regions

This segment highlights the distribution of dermal fillers market across various geographies, such as North America, Europe, Asia-Pacific, MENA and LATAM. According to projections, North America is likely to capture more than 24% of the dermal fillers market share by value, and this trend is unlikely to change in the future.

Key Market Insights

The market report features an extensive study of the current market landscape, market size, market share, market analysis, market forecast and future opportunities for the companies involved in the manufacturing of dermal fillers. The dermal fillers market research report highlights the efforts of several companies manufacturing hyaluronic acid or non hyaluronic acid dermal fillers for this rapidly emerging market segment of the pharmaceutical industry. Key takeaways of the dermal fillers market research report are briefly discussed below.

Competitive Landscape of Dermal Filler Companies

The global dermal fillers market is highly fragmented, with the presence of international as well as regional players. Presently, more than 60 dermal filler companies are engaged in offering various formulations to fulfil aesthetic requirements of clients. Additionally, mid-sized firms constitute 44% of the total companies engaged in this industry. It is worth mentioning that 21% of the total dermal filler companies are based in Europe. Furthermore, 42% of the partnerships inked in the last five years were focused on facial aesthetics and around 21% are specifically focused on dermal filler formulations.

Dermal Fillers Market Drivers: Minimally Invasive Nature and Launch of Products Targeting Specific Requirements Will Drive the Market Growth

The dermal fillers market growth is being driven by several factors. Firstly, the minimally invasive nature of dermal filler injections attracts a broad segment of the population. This is primarily because people can attain desired results without getting under knife while offering additional benefits, such as fewer risks and short recovery timelines. Other minimally invasive procedure, which is widely popular is the botox injections. Secondly, the growing older and aging population paves the way for the increased demand of dermal filler procedures. In addition, hype fueled by social media influencers and some aestheticians can positively shape the market landscape of dermal fillers market. Furthermore, technological advancements, such as the development of long-lasting formulations can help in driving the future of dermal fillers market growth.

Companies are also launching products that target specific needs. Such as, Galderma launched RESTYLANE® EYELIGHT™ in Canada in May 2023 specifically for the correction of infraorbital hollowing. A number of companies also have innovative products in their pipeline and are partnering to expand into global markets. One such company, Evolus gained US distribution rights to a line of five dermal fillers from Symatese in May 2023, which are currently in late stage development with first approval expected in 1H 2025.

Dermal Fillers Market Opportunity Analysis: Demand for Sustainable and Biodegradable Materials

Development of combination and tailored formulations specific to the needs of the people will create an opportunity area for the dermal filler companies. Secondly, integration with advanced technologies, such as virtual reality, augmented reality and artificial intelligence can transform the dermal filler market by improving patient experience and treatment outcomes. AI can help in making customized procedures based on the unique characteristics of a patient whereas virtual reality and augmented reality can help the patient in choosing the right treatment option based on the simulated images. Further, development of sustainable and biodegradable materials can help in revolutionizing the beauty and plastic surgery industry, leading to greater number of opportunities for dermal filler companies.

Dermal Fillers Market Restraints: Cost of Procedure May Deter Adoption in Developing Countries

The dermal fillers market faces several restraints that may impact on its growth. One of the primary restraints is the risk of potential side effects. Some of the commonly experienced side effects include swelling, bruising and muscle weakening. However, post operative measures can help in overcoming these side effects. Secondly, stringent guidelines from regulatory bodies can limit the launch and introduction of novel products and formulations. In addition, the market may be restrained due to the high cost of quality dermal fillers that might not be affordable for certain populations. According to The Aesthetics Society, a filler procedure costs an average of $700. Furthermore, most of these types of procedures are performed by unlicensed medical practitioners resulting in some side effects and complications, deterring potential clients.

Dermal Fillers Market Analysis: Adoption is Increasing in the Males Segment

The dermal fillers market size is estimated to reach $8.8 billion by 2035, growing from $3 billion in 2023. Females hold the majority share (87%) of the dermal fillers market, though the adoption is increasing in the males segment. The number of minimally invasive procedures are increasing in men, as they look to enhance their cheeks, jawlines and the chin. As such, the according to the American Society of Plastic Surgeons (ASPS), while minimally invasive procedures in men have grown by 253% since 2019, the use of dermal fillers in men has increased by 70% during the period 2019 - 2022.

Regional Analysis: North America Holds Majority Dermal Fillers Market Share

North America is expected to dominate the revenue share, driving steady market expansion with a current market share of about 24%. According to the plastic surgery statistics report 2022, there were a total of more than 5.7 million dermal filler procedures in the US, which represented staggering 70% growth since 2019. Of these, 86% of the procedures were done using hyaluronic fillers, with rest accounting for non hyaluronic acid fillers. Additionally, majority of the dermal fillers were used by the 40-54 age group.

Moreover, Brazil is the second biggest market for dermal fillers, ranking after the US. The Asia-Pacific region is projected to experience the highest CAGR during the forecast period. This can be attributed to growing awareness regarding dermal filler procedures and increasing aesthetics medical tourism in this region.

Key Companies Engaged in Dermal Fillers Market

Examples of key companies in dermal fillers industry (the complete list of companies is available in the full report) include Allergan Aesthetics, Alma Lasers, Biotechitalia, Bison Medical, Koru Pharma, MedicalZone, Merz Pharma, Mesoestetic, MesoTech, NeoGenesis, Sinclair Pharma and Xcelene. This market report includes an easily searchable excel database of all the dermal filler companies worldwide.

Report Coverage

  • The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:
  • A preface providing an introduction to the full report, Dermal Fillers Market, 2018-2022 (Historical Trends) and 2023-2035 (Forecasted Estimates).
  • An outline of the systematic research methodology adopted to conduct the study on dermal fillers market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of the findings.
  • An overview of economic factors that impact the overall medical aesthetics industry, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
  • An executive summary of the key insights captured during the research, offering a high-level view on the current landscape of the dermal fillers market and its likely evolution in the short to mid and long term.
  • A general overview of medical aesthetics, highlighting details on dermal fillers, types, its advantages and disadvantages. It also features the emerging technologies being applied for medical aesthetic procedures.
  • A comprehensive assessment of the overall market landscape of dermal filler companies, based on several relevant parameters such as year of establishment, company size and location of headquarters. The companies have also been analysed by the application area and end user.
  • Elaborate profiles of prominent companies (shortlisted based on product portfolio strength) engaged in dermal fillers market. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and leadership team), details related to product portfolio, recent developments and an informed future outlook.
  • An insightful company competitiveness analysis based on various relevant parameters.
  • A detailed analysis of the partnerships inked between stakeholders in dermal fillers market, since 2018 covering acquisitions, product / technology integration agreements, distribution agreements, service alliances, commercialization agreements, research agreements and other relevant agreements.
  • An analysis of the funding and investments made in dermal filler companies, since 2018, through seed financing, venture capital financing, IPOs, secondary offerings, grants / awards, private placements, other equity and debt financing, at various stages of development of such companies, based on several parameters, such as year of investment, amount invested, type of funding, investment focus area, leading players, key investors, and geographical analysis.
  • An in-depth analysis of the factors that can impact the growth of dermal fillers market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
  • A detailed estimate of the current market size, opportunity and the future growth potential of the dermal fillers market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period 2023-2035. The report also features the likely distribution of the current and forecasted opportunity within the dermal fillers industry. Further, in order to account for future uncertainties and to add robustness to the model, the analyst has provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A detailed projection of the current and future dermal fillers market across end user, such as hospitals, clinics / med spas and dermatology / cosmetology centers, and other end users.
  • A detailed projection of the current and future dermal fillers market across different gender, including females and males.
  • A detailed projection of the current and future dermal fillers industry across different distribution channels, including direct distribution and indirect distribution.
  • A detailed projection of the current and future market across key geographical regions, such as North America, Europe, Asia-Pacific, MENA and LATAM.
  • A detailed estimate of the future growth potential of the dermal filler products market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period.

Recent Developments in Dermal Fillers Market

Several recent developments have taken place in the dermal fillers industry, some of which have been outlined below. These developments, even if they took place post the release of the market report, substantiate the overall market trends that have been outlined in the analysis:

  • In May 2022, BioPlus entered into a joint venture agreement with Chimin Health for the expansion of their development abilities for hyaluronic acid based dermal fillers in the Chinese market.
  • In February 2021, Pharmaresearch collaborated with Yxintent for the distribution of Rejuran fillers in Chinese market. The collaboration includes the supply of four types of fillers intended for various areas of face, specifically in eliminating wrinkles and scars.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Inclusions and Exclusions
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Ris
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics
5.4. Dermal Fillers
5.5. Advantages of Dermal Fillers
5.6. Side Effects of Dermal Fillers
5.7. Key Growth Drivers of Medical Aesthetics
5.8. Emerging Technologies in Medical Aesthetics
5.8.1. Virtual Reality in Medical Aesthetics
5.8.2. Augmented Reality in Medical Aesthetics
5.8.3. Artificial Intelligence in Medical Aesthetics
5.8.4. Telemedicine in Medical Aesthetics
5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Dermal Fillers: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
6.2.6. Analysis by Company Size and Location of Headquarters (Region)
6.2.7. Analysis by Application Area
6.2.8. Analysis by End-user
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Allergan Aesthetics
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Medical Aesthetics Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Croma Pharma
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Medical Aesthetics Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. Galderma
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Medical Aesthetics Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. IBSA
7.5.1. Company Overview
7.5.2. Medical Aesthetics Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Sinclair Pharma
7.6.1. Company Overview
7.6.2. Medical Aesthetics Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
8.4.1. Companies based in North America
8.4.2. Companies based in Europe
8.4.3 Companies based in Asia-Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Dermal Fillers: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.4. Analysis by Geography
9.4.1. Local and International Agreements
9.4.2. Intracontinental and Intercontinental Agreements
10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Dermal Fillers: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Geography
10.3.7. Most Active Players
10.3.7.1. Analysis by Number of Funding Instances
10.3.7.2. Analysis by Amount Raised
10.3.9. Analysis by Company Size and Amount Invested
10.3.10. Leading Investors: Analysis by Number of Funding Instances
10.4. Concluding Remarks
11. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion
12. GLOBAL DERMAL FILLERS MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
12.3.1. Scenario Analysis
12.3.1.1. Conservative Scenario Analysis
12.3.1.2. Optimistic Scenario Analysis
12.4. Key Market Segmentations
12.5. Dynamic Dashboards
13. DERMAL FILLERS MARKET, BY END-USER
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035
13.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.4. Data Triangulation and Validation
14. DERMAL FILLERS MARKET, BY GENDER
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035
14.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.4. Data Triangulation and Validation
15. DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Dermal Fillers Market, by Distribution Channel, 2015, 2023 and 2035
15.3.1. Direct Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
15.3.2. Indirect Distribution: Historical Trends (2015-2022) and Forecasted Estimates (2023-2035)
15.4. Data Triangulation and Validation
16. DERMAL FILLERS MARKET, BY KEY GEOGRAPHICAL REGION
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Dermal Fillers Market: Distribution by Key Geographical Regions, 2016, 2023 and 2035
16.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.1.1. US: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.1.2. Canada: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.1.3. Mexico: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.1. UK: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.2. Germany: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.3. France: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.4. Italy: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.5. Spain: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.5. Rest of the Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3.1. China: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3.2. South Korea Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3.3. Japan: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3.4. India: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.4.1. Turkey: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.4.2. Iran: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.5.1. Brazil: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.5.2. Argentina: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.5.3. Rest of the Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Data Triangulation and Validation
17. DERMAL FILLERS PRODUCT MARKET
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Dermal Fillers Products Market, by Key Geographical Regions, 2018, 2023 and 2035
17.4.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Data Triangulation and Validation
18. EXECUTIVE INSIGHTS19. CONCLUSION20. APPENDIX 1: TABULATED DATA21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Funding and Investments
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Advantages of Medical Aesthetics
Figure 5.2 Side Effects of Medical Aesthetics
Figure 6.1 Dermal Fillers Market Landscape: Distribution by Year of Establishment
Figure 6.2 Dermal Fillers Market Landscape: Distribution by Company Size
Figure 6.3 Dermal Fillers Market Landscape: Distribution by Location of Headquarters (Region)
Figure 6.4 Dermal Fillers Market Landscape: Distribution by Location of Headquarters (Country)
Figure 6.5 Dermal Fillers Market Landscape: Distribution by Year of Establishment and Location of Headquarters (Region)
Figure 6.6 Dermal Fillers Market Landscape: Distribution by Company Size and Location of Headquarters (Region)
Figure 6.7 Dermal Fillers Market Landscape: Distribution by Application Area
Figure 6.8 Dermal Fillers Market Landscape: Distribution by End-user
Figure 7.1 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Figure 7.2 Croma Pharma: Annual Revenues, FY 2021-H1 FY 2022 (EUR Million)
Figure 7.3 Galderma: Annual Revenues, FY 2020-FY H1 2023 (USD Billion)
Figure 8.1 Company Competitiveness Analysis: Companies based in North America
Figure 8.2 Company Competitiveness Analysis: Companies based in Europe
Figure 8.3 Company Competitiveness Analysis: Companies based in Asia-Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Figure 9.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.5 Most Active Players: Distribution by Number of Partnerships
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Figure 10.2 Funding and Investments: Distribution by Amount Invested (USD Million)
Figure 10.3 Funding and Investments: Distribution by Type of Funding
Figure 10.4 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Figure 10.5 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.6 Funding and Investments: Distribution by Geography (Region)
Figure 10.7 Funding and Investments: Distribution by Geography (Country)
Figure 10.8 Most Active Players: Distribution by Number of Funding Instances
Figure 10.9 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.10 Leading Investors: Distribution by Number of Funding Instances
Figure 10.11 Funding and Investments: Distribution by Company Size and Amount Invested
Figure 10.12 Funding and Investments Summary, 2018-2023 (USD Million)
Figure 11.1 Market Drivers
Figure 11.2 Market Restraints
Figure 11.3 Market Opportunities
Figure 11.4 Market Challenges
Figure 12.1 Global Dermal Fillers Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 12.2 Global Dermal Fillers Market, 2023-2035: Conservative Scenario (USD Million)
Figure 12.3 Global Dermal Fillers Market, 2023-2035: Optimistic Scenario (USD Million)
Figure 12.4 Dynamic Dashboard
Figure 13.1 Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Figure 13.2 Dermal Fillers Market for Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 13.3 Dermal Fillers Market for Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 13.4 Dermal Fillers Market for Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.1 Dermal Fillers Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Figure 14.2 Dermal Fillers Market for Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.3 Dermal Fillers Market for Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.1 Dermal Fillers Market for Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Dermal Fillers Market for Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.3 Dermal Fillers Market for Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.1 Dermal Fillers Market for Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Million)
Figure 16.2 Dermal Fillers Market in North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.3 Dermal Fillers Market in US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.4 Dermal Fillers Market in Canada: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.5 Dermal Fillers Market in Mexico: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.6 Dermal Fillers Market in Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.7 Dermal Fillers Market in UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.8 Dermal Fillers Market in Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.9 Dermal Fillers Market in France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.10 Dermal Fillers Market in Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.11 Dermal Fillers Market in Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.12 Dermal Fillers Market in Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.13 Dermal Fillers Market in Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.14 Dermal Fillers Market in China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.15 Dermal Fillers Market in South Korea: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.16 Dermal Fillers Market in Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.17 Dermal Fillers Market in India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.19 Dermal Fillers Market in Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.19 Dermal Fillers Market in Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.20 Dermal Fillers Market in Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.21 Dermal Fillers Market in Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.22 Dermal Fillers Market in Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.23 Dermal Fillers Market in Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.24 Dermal Fillers Market in Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.25 Dermal Fillers Market in Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.1 Global Dermal Fillers Product Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.2 Dermal Fillers Product Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Figure 17.3 Dermal Fillers Product Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.4 Dermal Fillers Product Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.5 Dermal Fillers Product Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.6 Dermal Fillers Product Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.7 Dermal Fillers Product Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.1 Conclusion: Market Landscape
Figure 19.2 Conclusion: Partnerships and Collaborations
Figure 19.3 Conclusion: Funding and Investments
Figure 19.4 Conclusion: Market Forecast and Opportunity Analysis
LIST OF TABLES
Table 6.1 Dermal Fillers Market Landscape: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.2 Dermal Fillers Market Landscape: Information on Application Area
Table 6.3 Dermal Fillers Market Landscape: Information on End-user
Table 7.1 Dermal Fillers: List of Profiled Companies
Table 7.2 Allergan Aesthetics: Company Overview
Table 7.3 Allergan Aesthetics: Medical Aesthetics Portfolio
Table 7.4 Allergan Aesthetics: Recent Developments and Future Outlook
Table 7.5 Croma Pharma: Company Overview
Table 7.6 Croma Pharma: Medical Aesthetics Portfolio
Table 7.7 Croma Pharma: Recent Developments and Future Outlook
Table 7.8 Galderma: Company Overview
Table 7.9 Galderma: Medical Aesthetics Portfolio
Table 7.10 Galderma: Recent Developments and Future Outlook
Table 7.11 IBSA: Company Overview
Table 7.12 IBSA: Medical Aesthetics Portfolio
Table 7.13 IBSA: Recent Developments and Future Outlook
Table 7.14 Sinclair Pharma: Company Overview
Table 7.15 Sinclair Pharma: Medical Aesthetics Portfolio
Table 9.1 Dermal Fillers: List of Partnerships and Collaborations
Table 9.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 10.1 Dermal Fillers: List of Funding and Investments
Table 11.1 Medical Aesthetics: Impact of Internal and External Factors on Key Players
Table 20.1 Dermal Filler Companies: Distribution by Year of Establishment
Table 20.2 Dermal Filler Companies: Distribution by Company Size
Table 20.3 Dermal Filler Companies: Distribution by Location of Headquarters (Region)
Table 20.4 Dermal Filler Companies: Distribution by Location of Headquarters (Country)
Table 20.5 Dermal Filler Companies: Distribution by Year of Establishment and Location of Headquarters (Region)
Table 20.6 Dermal Filler Companies: Distribution by Company Size and Location of Headquarters (Region)
Table 20.7 Dermal Filler Companies: Distribution by Application Area
Table 20.8 Dermal Filler Companies: Distribution by End-user
Table 20.9 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Table 20.10 Croma Pharma: Annual Revenues, FY 2021-FY 2022 (EUR Million)
Table 20.11 Galderma: Annual Revenues, FY 2020- H1 FY 2023 (USD Billion)
Table 20.12 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Table 20.13 Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Table 20.15 Partnerships and Collaborations: Distribution by Focus Area
Table 20.16 Most Active Players: Distribution by Number of Partnerships
Table 20.17 Partnerships and Collaborations: Local and International Agreements
Table 20.18 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 20.19 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Table 20.20 Funding and Investments: Distribution by Type of Funding
Table 20.21 Funding and Investments: Distribution by Amount Invested (USD Million)
Table 20.22 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Table 20.23 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Table 20.24 Funding and Investments: Distribution by Geography (Region)
Table 20.25 Funding and Investments: Distribution by Geography (Country)
Table 20.26 Most Active Players: Distribution by Number of Funding Instances
Table 20.27 Most Active Players: Distribution by Amount Raised (USD Million)
Table 20.28 Leading Investors: Distribution by Number of Funding Instances
Table 20.29 Funding and Investments: Distribution by Company Size and Amount Invested
Table 20.30 Funding and Investments Summary, 2018-2023 (USD Million)
Table 20.31 Global Dermal Fillers Market, 2018-2022 (USD Million)
Table 20.32 Global Dermal Fillers Market, 2023-2035 (USD Million)
Table 20.33 Global Dermal Fillers Market, 2023-2035: Conservative Scenario (USD Million)
Table 20.34 Global Dermal Fillers Market, 2023-2035: Optimistic Scenario (USD Million)
Table 20.35 Dermal Fillers Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Table 20.36 Dermal Fillers Market for Hospitals, 2018-2022 (USD Million)
Table 20.37 Dermal Fillers Market for Hospitals, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.38 Dermal Fillers Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, 2018-2022 (USD Million)
Table 20.39 Dermal Fillers Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.40 Dermal Fillers Market for Other End-users, 2018-2022 (USD Million)
Table 20.41 Dermal Fillers Market for Other End-users, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.42 Dermal Fillers Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Table 20.43 Dermal Fillers Market for Direct Distribution, 2018-2022 (USD Million)
Table 20.44 Dermal Fillers Market for Direct Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.45 Dermal Fillers Market for Indirect Distribution, 2018-2022 (USD Million)
Table 20.46 Dermal Fillers Market for Indirect Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.47 Dermal Fillers Market: Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Table 20.48 Dermal Fillers Market for Males, Conservative, 2018-2022 (USD Million)
Table 20.49 Dermal Fillers Market for Males, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.50 Dermal Fillers Market for Females, 2018-2022 (USD Million)
Table 20.51 Dermal Fillers Market for Females, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.52 Dermal Fillers Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 20.53 Dermal Fillers Market in North America, 2018-2022 (USD Million)
Table 20.54 Dermal Fillers Market in North America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.55 Dermal Fillers Market in US, 2018-2022 (USD Million)
Table 20.56 Dermal Fillers Market in US, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.57 Dermal Fillers Market in Canada, 2018-2022 (USD Million)
Table 20.58 Dermal Fillers Market in Canada, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.59 Dermal Fillers Market in Mexico, 2018-2022 (USD Million)
Table 20.60 Dermal Fillers Market in Mexico, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.61 Dermal Fillers Market in Europe, 2018-2022 (USD Million)
Table 20.62 Dermal Fillers Market in Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.63 Dermal Fillers Market in UK, 2018-2022 (USD Million)
Table 20.64 Dermal Fillers Market in UK, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.65 Dermal Fillers Market in Germany, 2018-2022 (USD Million)
Table 20.66 Dermal Fillers Market in Germany, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.67 Dermal Fillers Market in France, 2018-2022 (USD Million)
Table 20.68 Dermal Fillers Market in France, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.69 Dermal Fillers Market in Italy, 2018-2022 (USD Million)
Table 20.70 Dermal Fillers Market in Italy, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.71 Dermal Fillers Market in Spain, 2018-2022 (USD Million)
Table 20.72 Dermal Fillers Market in Spain, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.73 Dermal Fillers Market in Rest of the Europe, 2018-2022 (USD Million)
Table 20.74 Dermal Fillers Market in Rest of the Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.75 Dermal Fillers Market in Asia-Pacific, 2018-2022 (USD Million)
Table 20.76 Dermal Fillers Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.77 Dermal Fillers Market in China, 2018-2022 (USD Million)
Table 20.78 Dermal Fillers Market in China, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.79 Dermal Fillers Market in South Korea, 2018-2022 (USD Million)
Table 20.80 Dermal Fillers Market in South Korea, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.81 Dermal Fillers Market in Japan, 2018-2022 (USD Million)
Table 20.82 Dermal Fillers Market in Japan, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.83 Dermal Fillers Market in India, 2018-2022 (USD Million)
Table 20.84 Dermal Fillers Market in India, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.85 Dermal Fillers Market in Middle East and North Africa, 2018-2022 (USD Million)
Table 20.86 Dermal Fillers Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.87 Dermal Fillers Market in Turkey, 2018-2022 (USD Million)
Table 20.88 Dermal Fillers Market in Turkey, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.89 Dermal Fillers Market in Iran, 2018-2022 (USD Million)
Table 20.90 Dermal Fillers Market in Iran, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.91 Dermal Fillers Market in Rest of the Middle East and North Africa, 2018-2022 (USD Million)
Table 20.92 Dermal Fillers Market in Rest of the Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.93 Dermal Fillers Market in Latin America, 2018-2022 (USD Million)
Table 20.94 Dermal Fillers Market in Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.95 Dermal Fillers Market in Brazil, 2018-2022 (USD Million)
Table 20.96 Dermal Fillers Market in Brazil, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.97 Dermal Fillers Market in Argentina, 2018-2022 (USD Million)
Table 20.98 Dermal Fillers Market in Argentina, 2023-2035 (USD Million)
Table 20.99 Dermal Fillers Market in Rest of the Latin America, 2018-2022 (USD Million)
Table 20.100 Dermal Fillers Market in Rest of the Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.101 Global Dermal Fillers Product Market, Historical Trends, 2018-2022 (USD Million)
Table 20.102 Global Dermal Fillers Product Market, Historical Trends, 2023-2035 (USD Million)
Table 20.103 Dermal Fillers Product Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 20.104 Dermal Fillers Product Market in North America, 2018-2022 (USD Million)
Table 20.105 Dermal Fillers Product Market in North America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.106 Dermal Fillers Product Market in Europe, 2018-2022 (USD Million)
Table 20.107 Dermal Fillers Product Market in Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.108 Dermal Fillers Product Market in Asia-Pacific, 2018-2022 (USD Million)
Table 20.109 Dermal Fillers Product Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.110 Dermal Fillers Product Market in Middle East and North Africa, 2018-2022 (USD Million)
Table 20.111 Dermal Fillers Product Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 20.112 Dermal Fillers Product Market in Latin America, 2018-2022 (USD Million)
Table 20.113 Dermal Fillers Product Market in Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Allergan Aesthetics
  • Alma Lasers
  • Biotechitalia
  • Bison Medical
  • Koru Pharma
  • MedicalZone
  • Merz Pharma
  • Mesoestetic
  • MesoTech
  • NeoGenesis
  • Sinclair Pharma
  • Xcelene

Methodology

 

 

Loading
LOADING...

Table Information